Volume 15 Supplement 1
EHMTI-0206. Nigerian plants that are used for treatment of headache and migraine
- SA Saganuwan1
© Saganuwan; licensee Springer. 2014
Published: 18 September 2014
Migraine and headache are life-threatening ill-conditions that affect the active, industrious class, which may likely reduce productivity.
Because plants serve as source of 1 in every 4 drugs on drug market, there is need for survey of literatures with a view to identifying Nigerian medicinal plants with potential activity against migraine and headache.
Literature survey and photography of medicinal plants that are used in Nigeria was carried out with a view to identify medicinal plants with therapeutic potentials against headache and migraine.
Out of 184 medicinal plants identified, 23 have activity against migraine 29 have activity against both headache and migraine and 132 have activity against headache respectively. Orchis mascula, Hollarhena floribunda, Malaleuca leucodeudron, Cinnamomum zeylanicum, Citrus aurantifolium, Luffa accutangula Brassica juncea, Brassica nigra, Ocimum basilicum, Citrus aurantium Petasites hybridus, Rothmania whitfeildi, Palisota hirsuta, Crassocephalum crepidioides, Pridelia micrantha, Parkia bicolor, Cycodiscus gabonensis, Abelmoschus maschattus, Adenia venenata, Culcasia scandens, Dioscorea dumentorun, Galinsoga parviflora, Kolobopetalun auriculatum, Matricaria recutita, Petveria alliance, Piper nigran, Spilanthes filicaulis, Tragia benthani and Nigella sativa have activity against migraine and headache. Decoctions, infusions, concoctions and vapour of roots, leaves, stembark, flowers, and oil of the plants are used for the relief of the conditions. Since hypertension can cause headache plants such as Nigella sativa, Ocimum basilicum, chloriandrum sativum may be used to treat both migraine and headache caused by hypertension.
Therefore medicinal plant resources from Africa should be harnessed with a view to discovering additional novel drugs with activity against headache and migraine.
No conflict of interest.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.